STOCK TITAN

Insider plans PTCT (NASDAQ: PTCT) sale of 881 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider has filed a notice of intent to sell 881 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of 67,351.66. The issuer reports 80,288,305 shares of this class outstanding, and the approximate sale date is 01/08/2026 on NASDAQ.

The 881 shares to be sold were acquired on 01/07/2026 via restricted stock vesting from the issuer as compensation. Over the past three months, Neil G. Almstead has sold multiple blocks of common shares, including 35,572 shares on 11/24/2025 for 2,852,153.65, 71,928 shares on 11/25/2025 for 6,001,524.59, 1,279 shares on 01/06/2026 for 98,415.98, and 1,026 shares on 01/07/2026 for 79,498.38. Zheng Y. Almstead sold 54 shares on 01/06/2026 for 4,155.17 and 52 shares on 01/07/2026 for 4,029.16.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for PTCT disclose?

This notice discloses an insider’s intent to sell 881 shares of common stock with an aggregate market value of 67,351.66, to be sold through Fidelity Brokerage Services LLC on NASDAQ.

How and when were the 881 PTCT shares to be sold acquired?

The 881 common shares were acquired on 01/07/2026 via restricted stock vesting from the issuer, and the consideration is described as compensation.

How many PTCT shares are outstanding for this class?

The filing reports that 80,288,305 shares of the relevant class of common stock were outstanding at the time referenced.

What prior PTCT share sales by Neil G. Almstead are reported?

Neil G. Almstead sold 35,572 shares on 11/24/2025 for 2,852,153.65, 71,928 shares on 11/25/2025 for 6,001,524.59, 1,279 shares on 01/06/2026 for 98,415.98, and 1,026 shares on 01/07/2026 for 79,498.38.

What PTCT stock sales by Zheng Y. Almstead are listed in the past 3 months?

Zheng Y. Almstead is reported to have sold 54 common shares on 01/06/2026 for 4,155.17 and 52 common shares on 01/07/2026 for 4,029.16.

Which exchange and broker are involved in the planned PTCT share sale?

The Form 144 indicates the intended sale of common stock on NASDAQ through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island.

Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

5.47B
80.53M
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN